A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy (Q37604518)
Jump to navigation
Jump to search
scientific article published on 06 July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy |
scientific article published on 06 July 2015 |
Statements
1 reference
A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy (English)
1 reference
Anna Sylwestrzak
1 reference
Piotr Leszczyński
1 reference
Wieslawa Porawska
1 reference
Asta Baranauskaite
1 reference
Vira Tseluyko
1 reference
Vyacheslav M Zhdan
1 reference
Barbara Stasiuk
1 reference
Roma Milasiene
1 reference
Aaron Alejandro Barrera Rodriguez
1 reference
Soo Yeon Cheong
1 reference
Jeehoon Ghil
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference